Lulizumab

Modify Date: 2024-09-16 18:58:05

Lulizumab structure	Common Name	Lulizumab
	CAS Number	2235419-62-0	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Lulizumab

Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling[1].

Properties
Spectrum

Name	Lulizumab

Description	Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling[1].
Related Catalog	Research Areas >> Inflammation/Immunology
References	[1]. Fernandes JC. Therapeutic application of antibody fragments in autoimmune diseases: current state and prospects. Drug Discov Today. 2018 Dec;23(12):1996-2002.

No Any Chemical & Physical Properties

Lulizumab

Use of Lulizumab

Names

Lulizumab Biological Activity

Chemical & Physical Properties